Generally, it is agreed that HIF-1A is involved which modulates the expression of VEGF-A, and angiopoietin-1, thus increasing tumour angiogenesis, glycolysis and cellproliferation [15,16,17]. The gene discussed is VEGFA; the disease is neoplasm.